R&D Systems™ Recombinant Human LAR Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Supplier:  R&D Systems™ 9377PF050

Catalog No. 93-77P-F050

Description

Measured by its binding ability in a functional ELISA. When Recombinant Human LRFN5 Fc Chimera (Catalog # 9385-SA ) is used at 1 μg/mL, the concentration of Recombinant Human LAR that produces 50% optimal binding response is 1.5-9 μg/mL.

Specifications

• Accession Number: P10586-2
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 5792
• Quantity: 50 μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Gene Alias: LCA-homolog, protein tyrosine phosphatase, receptor type, F, PTPRF, receptor type, F polypeptide, receptor-linked protein-tyrosine phosphatase LAR, receptor-type tyrosine-protein phosphatase F
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Protein: LAR/PTPRF

• Characterization: Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with BSA and Trehalose.
• Molecular Weight (g/mol): M.W. (Observed): 114-146 kDa and 14 kDa, reducing conditions; M.W. (theoretical): 136 kDa
• Source: Mouse myeloma cell line, NS0-derived human LAR protein Ala27-Glu1251 with a C-terminal 6-His tag, and its proteolyzed forms Ala27-Arg1169 and Gln1170-Glu1251 with a C-terminal 6-His tag
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Product Type: Recombinant Protein
• Species: Human
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.